Virtual Therapy for Anxiety and Mood Disorders
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests how well children engage with virtual therapy for anxiety and mood issues. It compares a new therapy platform, Teleo, with regular video calls like Zoom. The trial aims to determine if Teleo improves therapy adherence in children. It suits children already using Teleo and diagnosed with a mental health condition. As an unphased trial, it provides a unique opportunity for children to contribute to innovative therapy research.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the Teleo virtual therapy platform is safe for children undergoing psychotherapy?
Research has shown that virtual therapy, such as Teleo, provides a safe way to receive mental health treatment from home. Teleo ensures privacy by adhering to strict confidentiality rules. However, specific safety guidelines for home-based therapy do not exist. Some therapists express concerns about potential issues, such as technology problems or the therapy's effectiveness for certain individuals. Despite these concerns, virtual therapy is widely used and generally effective for patients.12345
Why are researchers excited about this trial?
Researchers are excited about Teleo because it offers a unique approach to virtual therapy for anxiety and mood disorders. Unlike traditional videoconferencing tools like Zoom, Teleo is specifically designed for therapeutic use, potentially enhancing the efficacy of virtual sessions. This specialized platform may provide a more tailored and effective therapy experience, which is why it's generating interest as a promising alternative to standard video platforms.
What evidence suggests that the Teleo virtual therapy platform is effective for anxiety and mood disorders?
Research has shown that online cognitive behavior therapy (ICBT) effectively treats anxiety and depression, leading to significant improvements. In this trial, participants will receive therapy through various virtual platforms. Teleo, a virtual therapy platform tested in this trial, aims to enhance remote therapy for children. Studies suggest that telehealth services, such as Teleo, are as effective as face-to-face therapy in reducing depression symptoms. Additionally, virtual reality therapy has improved anxiety. These findings suggest that Teleo could be a valuable tool for managing anxiety and mood disorders in young people.12467
Who Is on the Research Team?
David S Hong, MD
Principal Investigator
Stanford University
Are You a Good Fit for This Trial?
This trial is for children with mood or anxiety disorders who are undergoing psychotherapy. It's designed to see if a virtual therapy platform called Teleo increases engagement compared to standard videoconferencing. Families willing to participate in four therapy sessions and have their child's engagement measured can join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive psychotherapy through either the Teleo virtual therapy platform or standard video conferencing for 4 sessions
Follow-up
Participants are monitored for engagement and outcomes post-intervention
What Are the Treatments Tested in This Trial?
Interventions
- Teleo
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
MainSquare Co. (dba 'Teleo')
Collaborator
National Institute of Mental Health (NIMH)
Collaborator